LUNG vs LVS · rev $43.3M vs P/E 28, rev $6.74B
Pulmonx Corp (LUNG) versus Las Vegas Sands Corp (LVS) — a side-by-side from cached financials, not a winner call.
Pulmonx Corp (LUNG) is a medical devices company listed on US.
Las Vegas Sands Corp (LVS) is a resorts & casinos company listed on US.
Latest reported LUNG revenue for 2026-06-30 was $43.3M. Net income was -$23.7M. LUNG currently screens at market cap $111.9M.
Latest reported LVS revenue for 2026-06-30 was $6.74B. Net income was $913.0M. Revenue was up 88.0% from 2026-03-31 to 2026-06-30. LVS currently screens at market cap $35.70B and trailing P/E 28.3.
LUNG currently screens at market cap $111.9M. LVS currently screens at market cap $35.70B and trailing P/E 28.3.
Not investment advice. Open the LUNG and LVS stock pages for the full models.
Not investment advice.